|
MY125870A
(en)
*
|
1997-07-25 |
2006-08-30 |
Alza Corp |
Osmotic delivery system flow modulator apparatus and method
|
|
AR013256A1
(es)
|
1997-12-30 |
2000-12-13 |
Intarcia Therapeutics Inc |
DISPOSICIoN DE ADMINISTRACIoN PARA UNA ADMINISTRACIoN CONTROLADA DE UN AGENTE BENÉFICO, MÉTODO PARA FORMAR UNA DISPOSICIoN DE ADMINISTRACIoN , MÉTODO PARA HACER UNA DISPOSICIoN DE ADMINISTRACIoN Y MÉTODO DE CONTROLAR UNA VELOCIDAD DE LIBERACIoN.
|
|
NZ512671A
(en)
*
|
1998-12-31 |
2003-12-19 |
Alza Corp |
Osmotic delivery system having space efficient piston
|
|
US7919109B2
(en)
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
|
US7258869B1
(en)
*
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
|
US6541021B1
(en)
*
|
1999-03-18 |
2003-04-01 |
Durect Corporation |
Devices and methods for pain management
|
|
US6835194B2
(en)
*
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
|
US6436091B1
(en)
*
|
1999-11-16 |
2002-08-20 |
Microsolutions, Inc. |
Methods and implantable devices and systems for long term delivery of a pharmaceutical agent
|
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
|
US6491684B1
(en)
*
|
2001-05-22 |
2002-12-10 |
Durect Corporation |
Fluid delivery device having a water generating electrochemical/chemical pump and associated method
|
|
US7163688B2
(en)
*
|
2001-06-22 |
2007-01-16 |
Alza Corporation |
Osmotic implant with membrane and membrane retention means
|
|
US8061006B2
(en)
*
|
2001-07-26 |
2011-11-22 |
Powderject Research Limited |
Particle cassette, method and kit therefor
|
|
WO2004000284A1
(en)
*
|
2002-06-21 |
2003-12-31 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
|
US7927613B2
(en)
*
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
|
US7790905B2
(en)
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
|
JP4906233B2
(ja)
|
2002-03-01 |
2012-03-28 |
ユニバーシティー オブ サウス フロリダ |
少なくとも１種の有効薬剤成分を含有する多構成要素固相
|
|
US20060116663A1
(en)
*
|
2002-05-01 |
2006-06-01 |
Joshi Ashok V |
Electro-osmotic fluid delivery device and method
|
|
US7458965B2
(en)
*
|
2002-05-01 |
2008-12-02 |
Microlin, Llc |
Fluid delivery device having an electrochemical pump with an ion-exchange membrane and associated method
|
|
US7470267B2
(en)
*
|
2002-05-01 |
2008-12-30 |
Microlin, Llc |
Fluid delivery device having an electrochemical pump with an anionic exchange membrane and associated method
|
|
US7896867B2
(en)
*
|
2002-05-01 |
2011-03-01 |
Microlin, Llc |
Fluid delivery device having an electrochemical pump with an ion-exchange membrane and associated method
|
|
WO2007005565A2
(en)
*
|
2002-05-01 |
2007-01-11 |
Microlin, Llc |
Fluid delivery device having an electrochemical pump with an ion-exchange membrane and associated method
|
|
MXPA04012976A
(es)
*
|
2002-06-17 |
2005-05-16 |
Alza Corp |
Sistema de distribucion osmotica con medio de potencia de empuje de orden cero temprana que comprende un agente osmotico disperso en el vehiculo fluido.
|
|
WO2004002565A1
(en)
*
|
2002-06-26 |
2004-01-08 |
Alza Corporation |
Minimally compliant, volume efficient piston for osmotic drug delivery systems
|
|
DE10233622A1
(de)
*
|
2002-07-24 |
2004-02-12 |
Disetronic Licensing Ag |
Infusionspumpe, Verfahren, Steuerprogramm und Halbleiterbauelement zur dosierten Verabreichung einer medizinischen Flüssigkeit
|
|
KR20050088196A
(ko)
*
|
2002-12-19 |
2005-09-02 |
알자 코포레이션 |
안정한 비수성 단일 상 겔 및 이식가능한 장치로부터전달하기 위한 이의 제형
|
|
US7731947B2
(en)
*
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
US8183290B2
(en)
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
|
EP2339328A3
(en)
|
2002-12-30 |
2011-07-13 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of celecoxib
|
|
JP4923182B2
(ja)
|
2003-02-28 |
2012-04-25 |
マクニール−ピーピーシー・インコーポレーテツド |
セレコキシブ及びニコチンアミド共結晶並びにこの共結晶を含む医薬組成物
|
|
JP2006521898A
(ja)
*
|
2003-03-31 |
2006-09-28 |
アルザ・コーポレーション |
浸透送り出しシステム及び浸透送り出しシステムの始動時間を短縮する方法
|
|
CL2004000696A1
(es)
*
|
2003-03-31 |
2005-05-20 |
Alza Corp |
Bomba osmotica, esta formada por una cubierta cilindrica con una camara que recibe al agente osmotico, un extremo abierto que recibe un tapon semipermeable y un orificio de ventilacion en la pared lateral ubicado proximo al extremo abierto, para disi
|
|
US20040214893A1
(en)
*
|
2003-04-11 |
2004-10-28 |
Matthew Peterson |
Gabapentin compositions
|
|
US7186863B2
(en)
|
2003-05-23 |
2007-03-06 |
Transform Pharmaceuticals, Inc. |
Sertraline compositions
|
|
US20090208540A1
(en)
*
|
2003-08-11 |
2009-08-20 |
Indevus Pharmaceuticals, Inc. |
Implantable device for the delivery of naltrexone and methods of use thereof
|
|
CA2437639C
(en)
*
|
2003-08-11 |
2016-07-05 |
Valera Pharmaceuticals, Inc. |
Long term drug delivery devices with polyurethane based polymers and their manufacture
|
|
US7858110B2
(en)
*
|
2003-08-11 |
2010-12-28 |
Endo Pharmaceuticals Solutions, Inc. |
Long term drug delivery devices with polyurethane based polymers and their manufacture
|
|
US7632245B1
(en)
*
|
2003-08-18 |
2009-12-15 |
Medrad, Inc. |
Devices, systems and methods for delivery of a fluid into a patient during a magnetic resonance procedure
|
|
US7217351B2
(en)
*
|
2003-08-29 |
2007-05-15 |
Beta Micropump Partners Llc |
Valve for controlling flow of a fluid
|
|
US7927599B2
(en)
|
2003-09-08 |
2011-04-19 |
Ethicon, Inc. |
Chondrocyte therapeutic delivery system
|
|
US8257963B2
(en)
|
2007-06-01 |
2012-09-04 |
Depuy Mitek, Inc. |
Chondrocyte container and method of use
|
|
US7897384B2
(en)
*
|
2003-09-08 |
2011-03-01 |
Ethicon, Inc. |
Chondrocyte therapeutic delivery system
|
|
AU2004314693B2
(en)
|
2003-09-26 |
2011-04-07 |
Alza Corporation |
Drug coating providing high drug loading and methods for providing the same
|
|
NZ546183A
(en)
|
2003-09-26 |
2011-04-29 |
Alza Corp |
Controlled release formulations exhibiting an ascending rate of release
|
|
JP5563731B2
(ja)
*
|
2003-09-26 |
2014-07-30 |
アルザ・コーポレーシヨン |
オピオイドおよび非オピオイド鎮痛薬の制御放出製剤
|
|
US7241457B2
(en)
|
2003-09-30 |
2007-07-10 |
Alza Corporation |
Osmotically driven active agent delivery device providing an ascending release profile
|
|
WO2005044239A2
(en)
*
|
2003-10-31 |
2005-05-19 |
Alza Corporation |
Osmotic pump with self-retaining, fast-start membrane plug
|
|
US20050113410A1
(en)
*
|
2003-11-03 |
2005-05-26 |
Mark Tawa |
Pharmaceutical salts of zafirlukast
|
|
MXPA06003065A
(es)
*
|
2003-11-06 |
2006-05-31 |
Alza Corp |
Reductor de velocidad de imbibicion modular para uso con bomba osmotica implantable.
|
|
JP2007512359A
(ja)
|
2003-11-19 |
2007-05-17 |
メタバシス・セラピューティクス・インコーポレイテッド |
新規なリン含有甲状腺ホルモン様物質
|
|
WO2005092065A2
(en)
*
|
2004-03-25 |
2005-10-06 |
Transform Pharmaceuticals, Inc. |
Novel tricyclic compounds and related methods of treatment
|
|
US20050266087A1
(en)
*
|
2004-05-25 |
2005-12-01 |
Gunjan Junnarkar |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
|
US7803786B2
(en)
*
|
2004-06-17 |
2010-09-28 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions and related methods of use
|
|
US20060020253A1
(en)
*
|
2004-07-26 |
2006-01-26 |
Prescott Anthony D |
Implantable device having reservoir with controlled release of medication and method of manufacturing the same
|
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
|
US8779175B2
(en)
|
2004-10-25 |
2014-07-15 |
Synthonics, Inc. |
Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
|
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
|
MX2007006120A
(es)
|
2004-11-23 |
2007-12-07 |
Adamas Pharmaceuticals Inc |
Metodo y composicion para administrar a un sujeto un antagonista del receptor de nmda.
|
|
US8389578B2
(en)
|
2004-11-24 |
2013-03-05 |
Adamas Pharmaceuticals, Inc |
Composition and method for treating neurological disease
|
|
WO2006073779A1
(en)
*
|
2004-12-30 |
2006-07-13 |
Transform Phamaceuticals, Inc. |
Novel omeprazole forms and related methods
|
|
EP2361630A1
(en)
*
|
2005-02-03 |
2011-08-31 |
Intarcia Therapeutics, Inc |
Implantable drug delivery device comprising particles and an osmotic pump
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
ATE553122T1
(de)
|
2005-02-28 |
2012-04-15 |
Sangamo Biosciences Inc |
Antiangiogene methoden und zusammensetzungen
|
|
US7959938B2
(en)
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
|
EP1874282B1
(en)
|
2005-04-06 |
2010-09-15 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for treatment of cns disorders
|
|
US8348930B2
(en)
*
|
2005-07-01 |
2013-01-08 |
Microlin, Llc |
Fluid delivery device with a diffusion membrane and electrochemical pump
|
|
WO2007044910A1
(en)
*
|
2005-10-13 |
2007-04-19 |
Duke University |
Compositions for the treatment and prevention of heart disease and methods of using same
|
|
US20070179613A1
(en)
*
|
2006-01-30 |
2007-08-02 |
Sdgi Holdings, Inc. |
Passive lubricating prosthetic joint
|
|
MX2008011714A
(es)
|
2006-03-14 |
2008-11-12 |
Univ Southern California |
Dispositivo de mems y metodo de administracion de agentes terapeuticos.
|
|
DE602007009377D1
(de)
|
2006-05-30 |
2010-11-04 |
Intarcia Therapeutics Inc |
Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
|
|
CN101505694B
(zh)
*
|
2006-06-21 |
2012-02-22 |
庄臣及庄臣视力保护公司 |
用于递送活性试剂的泪点塞
|
|
US9474645B2
(en)
*
|
2006-06-21 |
2016-10-25 |
Johnson & Johnson Vision Care, Inc. |
Punctal plugs for the delivery of active agents
|
|
EP2359808B1
(en)
*
|
2006-08-09 |
2013-05-22 |
Intarcia Therapeutics, Inc |
Osmotic delivery systems and piston assemblies
|
|
US9114133B2
(en)
|
2006-08-25 |
2015-08-25 |
U.S. Dept. Of Veterans Affairs |
Method of improving diastolic dysfunction
|
|
US20080154243A1
(en)
*
|
2006-12-20 |
2008-06-26 |
Beta Micropump Partners Llc |
Delivery device for a fluid
|
|
US20080154242A1
(en)
*
|
2006-12-20 |
2008-06-26 |
Beta Micropump Partners Llc |
Delivery device for a fluid
|
|
US20080152510A1
(en)
*
|
2006-12-20 |
2008-06-26 |
Beta Micropump Partners Llc |
Valve for controlling flow of a primary fluid
|
|
KR20170085615A
(ko)
|
2007-02-09 |
2017-07-24 |
메타베이시스 테라퓨틱스, 인크. |
글루카곤 수용체의 길항제
|
|
CN104000779A
(zh)
|
2007-04-23 |
2014-08-27 |
精达制药公司 |
促胰岛素释放肽的混悬制剂及其应用
|
|
BRPI0815557A2
(pt)
|
2007-08-13 |
2015-02-18 |
Metabasis Therapeuticas Inc |
Atividaores de glicocinase
|
|
WO2009086112A2
(en)
|
2007-12-20 |
2009-07-09 |
University Of Southern California |
Apparatus and methods for delivering therapeutic agents
|
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
|
CA2726861C
(en)
|
2008-02-13 |
2014-05-27 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
US8061280B2
(en)
*
|
2008-04-10 |
2011-11-22 |
Microlin, Llc |
Apparatus and method for delivering beneficial liquids at steady rate
|
|
EP2891501B1
(en)
*
|
2008-05-08 |
2016-09-21 |
MiniPumps, LLC |
Methods of manufacture of drug-delivery pumps
|
|
ES2534864T3
(es)
|
2008-05-08 |
2015-04-29 |
Minipumps, Llc |
Bombas implantables y cánulas para las mismas
|
|
US9849238B2
(en)
|
2008-05-08 |
2017-12-26 |
Minipumps, Llc |
Drug-delivery pump with intelligent control
|
|
EP2799428B1
(en)
|
2008-08-13 |
2016-11-16 |
Metabasis Therapeutics, Inc. |
Glucagon antagonists
|
|
WO2010039643A1
(en)
*
|
2008-09-30 |
2010-04-08 |
Endo Pharmaceuticals Solutions Inc. |
Implantable device for the delivery of histrelin and methods of use thereof
|
|
JP2012504146A
(ja)
|
2008-09-30 |
2012-02-16 |
エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド． |
リスペリドン送達用埋め込み可能型装置およびその使用方法
|
|
EP2349200A1
(en)
*
|
2008-10-15 |
2011-08-03 |
Intarcia Therapeutics, Inc |
Highly concentrated drug particles, formulations, suspensions and uses thereof
|
|
CN102378637B
(zh)
*
|
2009-04-07 |
2014-12-24 |
皇家飞利浦电子股份有限公司 |
无阀给药装置
|
|
WO2011022484A1
(en)
|
2009-08-18 |
2011-02-24 |
Replenish Pumps. Llc |
Electrolytic drug-delivery pump with adaptive control
|
|
US8808257B2
(en)
*
|
2009-08-31 |
2014-08-19 |
Johnson & Johnson Vision Care, Inc. |
Methods and apparatus for pulsatile release of medicaments from a punctal plug
|
|
NO2462246T3
(enExample)
|
2009-09-28 |
2018-02-03 |
|
|
|
EP2482677A1
(en)
|
2009-09-30 |
2012-08-08 |
The Regents of The University of California |
Cofactors and methods for use for individuals
|
|
BR112012013487A2
(pt)
|
2009-12-02 |
2017-10-03 |
Adamas Pharmaceuticals Inc |
Composições de amantadina e métodos de uso
|
|
US8038650B2
(en)
*
|
2010-02-22 |
2011-10-18 |
Microsert Ltd. |
Slow release liquid drug delivery device
|
|
US8969327B2
(en)
|
2010-04-08 |
2015-03-03 |
Emory University |
Substituted androst-4-ene diones
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
US9585930B2
(en)
|
2011-03-20 |
2017-03-07 |
Trustees Of Boston University |
Therapeutic agent for emphysema and COPD
|
|
WO2013003697A1
(en)
|
2011-06-30 |
2013-01-03 |
Trustees Of Boston University |
Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
|
|
CA2841748C
(en)
|
2011-07-15 |
2021-06-15 |
Nusirt Sciences, Inc. |
Compositions and methods for modulating metabolic pathways
|
|
US9198454B2
(en)
|
2012-03-08 |
2015-12-01 |
Nusirt Sciences, Inc. |
Compositions, methods, and kits for regulating energy metabolism
|
|
CN104918610B
(zh)
|
2012-11-13 |
2018-04-10 |
纽斯尔特科学公司 |
用于增强能量代谢的组合物和方法
|
|
CN105101958B
(zh)
|
2013-01-15 |
2019-05-17 |
纽斯尔特科学公司 |
治疗肺病状
|
|
CN104001261A
(zh)
*
|
2013-02-27 |
2014-08-27 |
重庆市北碚区精神卫生中心 |
一种皮下给药装置
|
|
US10137287B2
(en)
*
|
2013-03-05 |
2018-11-27 |
Taris Biomedical Llc |
Drug delivery devices and methods for controlled drug release through device orifice
|
|
US9486573B2
(en)
|
2013-03-14 |
2016-11-08 |
Bayer Healthcare Llc |
Fluid delivery system and method of fluid delivery to a patient
|
|
JP6550370B2
(ja)
|
2013-03-15 |
2019-07-24 |
ニューサート サイエンシーズ， インコーポレイテッド |
脂質レベルを低下させるロイシンおよびニコチン酸
|
|
WO2014204933A1
(en)
|
2013-06-17 |
2014-12-24 |
Adamas Pharmaceuticals, Inc. |
Amantadine compositions and methods of use
|
|
RU2016105099A
(ru)
|
2013-07-17 |
2017-08-22 |
БАЙЕР ХелсКер ЛЛСи |
Устройство для инфузий с картриджем, используемое внутри тоннеля
|
|
EP3036226B1
(en)
|
2013-08-22 |
2020-01-08 |
The General Hospital Corporation |
Inhibitors of human 12/15-lipoxygenase
|
|
AU2015222754B2
(en)
|
2014-02-27 |
2020-06-25 |
Nusirt Sciences Inc. |
Compositions and methods for the reduction or prevention of hepatic steatosis
|
|
EP3154956A4
(en)
|
2014-06-12 |
2018-01-17 |
Ligand Pharmaceuticals, Inc. |
Glucagon antagonists
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
US10925639B2
(en)
|
2015-06-03 |
2021-02-23 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
|
JP7037490B2
(ja)
|
2015-11-05 |
2022-03-16 |
ザ ジェネラル ホスピタル コーポレイション |
副腎脊髄ニューロパチーの治療のためのａｂｃｄ１をコードする核酸配列の髄腔内送達
|
|
AU2016381366A1
(en)
|
2015-12-30 |
2018-06-28 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for the treatment of seizure-related disorders
|
|
TWI754643B
(zh)
|
2016-05-16 |
2022-02-11 |
美商因塔希亞治療公司 |
升糖素受體選擇性多肽和彼之使用方法
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
US10406336B2
(en)
|
2016-08-03 |
2019-09-10 |
Neil S. Davey |
Adjustable rate drug delivery implantable device
|
|
WO2018075901A1
(en)
|
2016-10-20 |
2018-04-26 |
Peptron, Inc. |
Methods of delivering a neuroprotective polypeptide to the central nervous system
|
|
WO2018129058A1
(en)
|
2017-01-03 |
2018-07-12 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
|
|
WO2018165462A1
(en)
|
2017-03-08 |
2018-09-13 |
Intarcia Therapeutics, Inc |
Apparatus and methods for administration of a nauseogenic compound from a drug delivery device
|
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
|
CN109583550A
(zh)
*
|
2017-09-28 |
2019-04-05 |
振锋企业股份有限公司 |
非接触式数据载体
|
|
CN111954560A
(zh)
|
2018-02-13 |
2020-11-17 |
配体药物公司 |
胰高血糖素受体拮抗剂
|
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
|
KR20210091705A
(ko)
|
2018-10-11 |
2021-07-22 |
인타르시아 세라퓨틱스 인코포레이티드 |
인간 아밀린 유사체 폴리펩타이드 및 사용 방법
|
|
CN110613888B
(zh)
*
|
2019-07-24 |
2022-03-08 |
南京中医药大学 |
耳塞式鼓室给药装置
|
|
ES1247524Y
(es)
*
|
2019-12-20 |
2020-08-28 |
Probodelt S L |
Dispositivo atrayente para dipteros
|
|
WO2025160155A1
(en)
|
2024-01-22 |
2025-07-31 |
The Broad Institute, Inc. |
Epigenetic targeting of prion diseases
|